F-star Therapeutics, Inc.·4

Jan 9, 4:04 PM ET

Race Geoffrey 4

4 · F-star Therapeutics, Inc. · Filed Jan 9, 2023

Insider Transaction Report

Form 4
Period: 2022-07-29
Transactions
  • Exercise/Conversion

    Common Stock

    2022-07-29$0.11/sh+3,937$4333,937 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2022-07-293,9373,937 total
    Exercise: $0.11Exp: 2029-12-18Common Stock (3,937 underlying)
Footnotes (3)
  • [F1]This Report is reporting the exempt exercise of employee stock options for cash payment thereof and receipt of the resulting shares. No shares were sold incidental to the exercise of these stock options.
  • [F2]This exercise price was originally reported incorrectly as $0.08 per share due to a conversion rate error from Pound Sterling into U.S. Dollars. Using the August 2022 approximate exchange rate of 1.2211, the exercise price in U.S. Dollars would be approximately $0.11 per share.
  • [F3]Shall vest in 12 equal monthly installments so long as he remains a director of the company.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION